INDOCO REMEDIES
Update On October 11, 2024 notification regarding the USFDA's Official Action Indicated (OAI) status for Plant II & III in Goa, India,
Co. received a warning letter from the USFDA on December 17, 2024.
The inspection took place from July 16 to 26, 2024.
Co. Says We remain committed to working with the USFDA to resolve the issues and uphold CGMP quality standards across our facilities.
We continue to supply products from the facility to meet our commitments to customers and patients in the USA.
Update On October 11, 2024 notification regarding the USFDA's Official Action Indicated (OAI) status for Plant II & III in Goa, India,
Co. received a warning letter from the USFDA on December 17, 2024.
The inspection took place from July 16 to 26, 2024.
Co. Says We remain committed to working with the USFDA to resolve the issues and uphold CGMP quality standards across our facilities.
We continue to supply products from the facility to meet our commitments to customers and patients in the USA.